<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34290398</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2042-0226</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cellular &amp; molecular immunology</Title><ISOAbbreviation>Cell Mol Immunol</ISOAbbreviation></Journal><ArticleTitle>Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>2128</StartPage><EndPage>2139</EndPage><MedlinePgn>2128-2139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41423-021-00728-2</ELocationID><Abstract><AbstractText>Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection induces an exacerbated inflammation driven by innate immunity components. Dendritic cells (DCs) play a key role in the defense against viral infections, for instance plasmacytoid DCs (pDCs), have the capacity to produce vast amounts of interferon-alpha (IFN-&#x3b1;). In COVID-19 there is a deficit in DC numbers and IFN-&#x3b1; production, which has been associated with disease severity. In this work, we described that in addition to the DC deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. Remarkably, previously hospitalized and nonhospitalized patients remained with decreased numbers of CD1c+ myeloid DCs and pDCs seven months after SARS-CoV-2 infection. Moreover, the expression of DC markers such as CD86 and CD4 were only restored in previously nonhospitalized patients, while no restoration of integrin &#x3b2;7 and indoleamine 2,3-dyoxigenase (IDO) levels were observed. These findings contribute to a better understanding of the immunological sequelae of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to CSI and USTC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>P&#xe9;rez-G&#xf3;mez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vitall&#xe9;</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gasca-Capote</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez-Valencia</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo-Rodriguez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serna-Gallego</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Muela</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Leon</LastName><ForeName>Mar&#xed;a de Los Reyes</ForeName><Initials>MLR</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafii-El-Idrissi Benhnia</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivas-Jeremias</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotomayor</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roca-Oporto</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Infante-Dom&#xed;nguez</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo-Rivas</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Villar</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pneumology Service, Galicia Sur Health Research Instituto (IIS Galicia Sur), SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Gonz&#xe1;lez</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Internal Medicine, Complexo HospitalarioUniversitario de Vigo, IIS Galicia Sur, SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Cort&#xe9;s</LastName><ForeName>Luis Fernando</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poveda</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Mateos</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Roc&#xed;o University Hospital, CSIC, University of Seville, Seville, Spain. eruizmateos-ibis@us.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Virgen del Roc&#xed;o Hospital COVID-19 Working Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CM20/00243</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant><Grant><GrantID>FI19/00083</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant><Grant><GrantID>CP19/00159</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cell Mol Immunol</MedlineTA><NlmUniqueID>101242872</NlmUniqueID><ISSNLinking>1672-7681</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dendritic cell</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cisneros</LastName><ForeName>Jos&#xe9; Miguel</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salto-Alejandre</LastName><ForeName>Sonsoles</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berastegui-Cabrera</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camacho-Mart&#xed;nez</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Infante-Dom&#xed;nguez</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carretero-Ledesma</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crespo-Rivas</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>M&#xe1;rquez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomas</LastName><ForeName>Jos&#xe9; Manuel</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bueno</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amaya</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lepe</LastName><ForeName>Jos&#xe9; Antonio</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pach&#xf3;n</LastName><ForeName>Jer&#xf3;nimo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cordero</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez-C&#xe9;spedes</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguilar-Guisado</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguilera</LastName><ForeName>Almudena</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguilera</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aldabo-Pallas</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alfaro-Lara</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amodeo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ampuero</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avil&#xe9;s</LastName><ForeName>Mar&#xed;a Dolores</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asensio</LastName><ForeName>Maribel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bar&#xf3;n-Franco</LastName><ForeName>Bosco</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barrera-Pulido</LastName><ForeName>Lydia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellido-Alba</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernabeu-Wittel</LastName><ForeName>M&#xe1;ximo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caballero-Eraso</LastName><ForeName>Candela</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Macarena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calder&#xf3;n</LastName><ForeName>Enrique</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carbajal-Guerrero</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cid-Cumplido</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcia-Palomo</LastName><ForeName>Yael</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delgado</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dom&#xed;nguez-Petit</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deniz</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dusseck-Brutus</LastName><ForeName>Reginal</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Escoresca-Ortega</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Espinosa</LastName><ForeName>F&#xe1;tima</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Nuria</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Espinoza</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferr&#xe1;ndiz-Mill&#xf3;n</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallego-Texeira</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xe1;mez-Mancera</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Emilio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a-Delgado</LastName><ForeName>Horacio</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a-Guti&#xe9;rrez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gasc&#xf3;n-Castillo</LastName><ForeName>Mar&#xed;a Luisa</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez-Estrada</LastName><ForeName>Aurora</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Demetrio</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xf3;mez-Gonz&#xe1;lez</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez-Le&#xf3;n</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grande-Cabrerizo</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guti&#xe9;rrez</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hern&#xe1;ndez-Quiles</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrera-Melero</LastName><ForeName>Inmaculada Concepci&#xf3;n</ForeName><Initials>IC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrero-Romero</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jara</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jim&#xe9;nez-Juan</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jim&#xe9;nez-Jorge</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jim&#xe9;nez-S&#xe1;nchez</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanseros-Tenllado</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Carmina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Barrios</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Cort&#xe9;s</LastName><ForeName>Luis F</ForeName><Initials>LF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luque-M&#xe1;rquez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mac&#xed;as-Garc&#xed;a</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;n-Guti&#xe9;rrez</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;n-Vill&#xe9;n</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molina</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morillo</LastName><ForeName>Aurora</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navarro-Amuedo</LastName><ForeName>Mar&#xed;a Dolores</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nieto-Mart&#xed;n</LastName><ForeName>Dolores</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ortega</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paniagua-Garc&#xed;a</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pe&#xf1;a-Rodr&#xed;guez</LastName><ForeName>Amelia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poyato</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Praena-Segovia</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>R&#xed;os</LastName><ForeName>Rafaela</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roca-Oporto</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>Jes&#xfa;s F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-Hern&#xe1;ndez</LastName><ForeName>Mar&#xed;a Jes&#xfa;s</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-Su&#xe1;rez</LastName><ForeName>Santiago</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-Villodres</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romero-Rodr&#xed;guez</LastName><ForeName>Nieves</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Azua</LastName><ForeName>Zida Ruiz</ForeName><Initials>ZR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salamanca</LastName><ForeName>Celia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez-Montagut</LastName><ForeName>V&#xed;ctor Manuel</ForeName><Initials>VM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sotomayor</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benjumea</LastName><ForeName>Alejandro Su&#xe1;rez</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toral</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34290398</ArticleId><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="doi">10.1038/s41423-021-00728-2</ArticleId><ArticleId IdType="pii">10.1038/s41423-021-00728-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;20. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Ren L, Zhang L, Zhong J, Xiao Y, Jia Z, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27:883&#x2013;90.e2. doi: 10.1016/j.chom.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, et al. Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. J Infect Dis. 2020;222:746&#x2013;54. doi: 10.1093/infdis/jiaa363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa363</ArticleId><ArticleId IdType="pmc">PMC7337752</ArticleId><ArticleId IdType="pubmed">32563194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvedaraite E, Hertwig L, Sinha I, Ponzetta A, Hed Myrberg I, Lourda M, et al. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity. Proc Natl Acad Sci USA. 2021;118:1&#x2013;12. doi: 10.1073/pnas.2018587118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2018587118</ArticleId><ArticleId IdType="pmc">PMC8017719</ArticleId><ArticleId IdType="pubmed">33479167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, To KKW, Wong YC, Liu L, Zhou B, Li X, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53:864&#x2013;77.e5. doi: 10.1016/j.immuni.2020.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7402670</ArticleId><ArticleId IdType="pubmed">32791036</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Cerrillo I, Landete P, Aldave B, S&#xe1;nchez-Alonso S, S&#xe1;nchez-Azofra A, Marcos-Jim&#xe9;nez A, et al. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes. J Clin Investig. 2020;130:6290&#x2013;300. doi: 10.1172/JCI140335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140335</ArticleId><ArticleId IdType="pmc">PMC7685723</ArticleId><ArticleId IdType="pubmed">32784290</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev. 2010;234:142&#x2013;62. doi: 10.1111/j.0105-2896.2009.00881.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2009.00881.x</ArticleId><ArticleId IdType="pmc">PMC3507434</ArticleId><ArticleId IdType="pubmed">20193017</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264:1918 LP&#x2013;21. doi: 10.1126/science.8009221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8009221</ArticleId><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing AG, Lorenc A, del Molino del Barrio I, Das A, Fish M, Monin L, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623&#x2013;35. doi: 10.1038/s41591-020-1038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Group for the GAC-19 P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Alculumbre SG, Saint-Andr&#xe9; V, Di Domizio J, Vargas P, Sirven P, Bost P, et al. Diversification of human plasmacytoid predendritic cells in response to a single stimulus. Nat Immunol. 2018;19:63&#x2013;75. doi: 10.1038/s41590-017-0012-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0012-z</ArticleId><ArticleId IdType="pubmed">29203862</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizis B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity. 2019;50:37&#x2013;50. doi: 10.1016/j.immuni.2018.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.12.027</ArticleId><ArticleId IdType="pmc">PMC6342491</ArticleId><ArticleId IdType="pubmed">30650380</ArticleId></ArticleIdList></Reference><Reference><Citation>Machmach K, Leal M, Gras C, Viciana P, Genebat M, Franco E, et al. Plasmacytoid dendritic cells reduce HIV Production in elite controllers. J Virol. 2012;86. 10.1128/JVI.07114-11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318617</ArticleId><ArticleId IdType="pubmed">22318133</ArticleId></ArticleIdList></Reference><Reference><Citation>Onodi F, Bonnet-Madin L, Meertens L, Karpf L, Poirot J, Zhang SY, et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J Exp Med. 2021;218. 10.1084/JEM.20201387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849819</ArticleId><ArticleId IdType="pubmed">33533916</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19:181&#x2013;93. doi: 10.1016/j.chom.2016.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.01.007</ArticleId><ArticleId IdType="pmc">PMC4752723</ArticleId><ArticleId IdType="pubmed">26867177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Chu H, Hou Y, Chai Y, Shuai H, Lee ACY, et al. Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J Infect Dis. 2020;222:734&#x2013;45. doi: 10.1093/infdis/jiaa356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa356</ArticleId><ArticleId IdType="pmc">PMC7337793</ArticleId><ArticleId IdType="pubmed">32563187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370. 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021. 10.1038/s41586-021-03234-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8567458</ArticleId><ArticleId IdType="pubmed">33494096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Liu Z, Moncada-Velez M, Chen J, Ogishi M, Bigio B, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370. 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol. 2021;23. 10.1038/s41556-021-00681-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33972731</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130:2620&#x2013;9. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Parackova Z, Zentsova I, Bloomfield M, Vrabcova P, Smetanova J, Klocperk A, et al. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils&#x2019; but Impaired Monocytes&#x2019; and Dendritic Cells&#x2019; Responsiveness. Cells. 2020;9:2206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600406</ArticleId><ArticleId IdType="pubmed">33003471</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wang Y, Li K, Meyerholz DK, Allamargot C, Perlman S. Severe acute respiratory syndrome coronavirus 2&#x2013;induced immune activation and death of monocyte-derived human macrophages and dendritic cells. J Infect Dis. 2020;52242:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799009</ArticleId><ArticleId IdType="pubmed">33277988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pribila JT, Itano AA, Mueller KL, Shimizu Y. The &#x3b1; 1 &#x3b2; 1 and &#x3b1; E &#x3b2; 7 integrins define a subset of dendritic cells in peripheral lymph nodes with unique adhesive and antigen uptake properties. J Immunol. 2004;172:282&#x2013;91. doi: 10.4049/jimmunol.172.1.282.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.1.282</ArticleId><ArticleId IdType="pubmed">14688336</ArticleId></ArticleIdList></Reference><Reference><Citation>Clahsen T, Pabst O, Tenbrock K, Schippers A, Wagner N. Localization of dendritic cells in the gut epithelium requires MAdCAM-1. Clin Immunol. 2015;156:74&#x2013;84. doi: 10.1016/j.clim.2014.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2014.11.005</ArticleId><ArticleId IdType="pubmed">25464027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, et al. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol. 2021;12:686240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2013;2. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox JM, Sage LK, Poore S, Johnson S, Tompkins SM, Tripp RA. Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection. J Leukoc Biol. 2014;96:447&#x2013;52. doi: 10.1189/jlb.3AB0114-046RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3AB0114-046RR</ArticleId><ArticleId IdType="pmc">PMC4138204</ArticleId><ArticleId IdType="pubmed">24799604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajamian F, Wu Y, Ebeling C, Ilarraza R, Odemuyiwa SO, Moqbel R, et al. Respiratory syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel role in the development of allergic disease. Clin Exp Allergy. 2015;45:644&#x2013;59. doi: 10.1111/cea.12498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12498</ArticleId><ArticleId IdType="pubmed">25627660</ArticleId></ArticleIdList></Reference><Reference><Citation>Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 2020;369:706&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292499</ArticleId><ArticleId IdType="pubmed">32527925</ArticleId></ArticleIdList></Reference><Reference><Citation>Barblu L, MacHmach K, Gras C, Delfraissy J-F, Boufassa F, Leal M, et al. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-and differentiate into functional killer pDCs under HIV activation. J Infect Dis. 2012;206. 10.1093/infdis/jis384.</Citation><ArticleIdList><ArticleId IdType="pubmed">22693234</ArticleId></ArticleIdList></Reference><Reference><Citation>Law HKW, Cheung CY, Sia SF, Chan YO, Peiris JSM, Lau YL. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol. 2009;10:1&#x2013;12. doi: 10.1186/1471-2172-10-35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-10-35</ArticleId><ArticleId IdType="pmc">PMC2700820</ArticleId><ArticleId IdType="pubmed">19505311</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuyama M, Ladinsky MS, Jha D, Cossarini F, Livanos AE, Reidy J, Tankelevich M, Martinez-Delgado G, Bjorkman PJ, Mehandru S. SARSCoV-2 persists in intestinal enterocytes up to 7 months after symptom resolution. Abstract 115. Conference on Retroviruses and Opportunistic Infections (CROI) 2021.</Citation></Reference><Reference><Citation>Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356:eaah4573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5775029</ArticleId><ArticleId IdType="pubmed">28428369</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19&#x2014;final report. N Engl J Med. 2020;383:1813&#x2013;26. doi: 10.1056/NEJMoa2007764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>